Correlation Between Bausch Health and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bausch Health and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bausch Health Companies and Aquestive Therapeutics, you can compare the effects of market volatilities on Bausch Health and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Aquestive Therapeutics.
Diversification Opportunities for Bausch Health and Aquestive Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Bausch and Aquestive is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Bausch Health i.e., Bausch Health and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Bausch Health and Aquestive Therapeutics
Considering the 90-day investment horizon Bausch Health Companies is expected to under-perform the Aquestive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bausch Health Companies is 2.01 times less risky than Aquestive Therapeutics. The stock trades about -0.31 of its potential returns per unit of risk. The Aquestive Therapeutics is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 552.00 in Aquestive Therapeutics on September 2, 2024 and sell it today you would lose (43.00) from holding Aquestive Therapeutics or give up 7.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bausch Health Companies vs. Aquestive Therapeutics
Performance |
| Timeline |
| Bausch Health Companies |
| Aquestive Therapeutics |
Bausch Health and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bausch Health and Aquestive Therapeutics
The main advantage of trading using opposite Bausch Health and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Bausch Health vs. Crinetics Pharmaceuticals | Bausch Health vs. Enanta Pharmaceuticals | Bausch Health vs. Amicus Therapeutics | Bausch Health vs. Connect Biopharma Holdings |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |